Liebow, Averill

Liebow, Averill A. 1965. Encounter with disaster—2l medical diary of Hiroshima, 1945. 

Closer still, in the heart of the city, no one survived to report the coming of the light the constrained witness of investigative groups must serve instead for testimony. A Yale Medical School pathologist working with a joint American-Japanese study commission a few months after the war, Averill A. Liebow, observes ... 

Oughterson, Ashley W, George V. LeRoy, Averil A. Liebow, E. Cuyler Hammond, Henry L. Barnett, Jack D. Rosenbaum, and B. Aubrey Schneider. Medical Effects of the Atomic Bomb in Japan, 6 vols. Vol. 6 declassified on December 28,1954. Washington, DC. U.S. Atomic Energy Commission, 1951. Limited distribution. 

LIP is part of a spectrum of pulmonary lymphoid proliferations that includes follicular bronchitis/bronchioUtis, NLH, and MALT B-cell lymphoma (4,5). They can be difficult to differentiate from each other (5,6). Indeed, a substantial percentage of the cases that were initially classified by Averill Liebow (3) as LIP were subsequently found to be mucosa-associated lymphoid tissue (MALT) lymphomas. As a result, LIP was excluded from the classification of idiopathic interstitial pneumonias for several decades. Today, it is clear that the majority of patients with LIP have associated immunologic disorders, dysproteinemias or viral infections, so that LIP can be viewed as a morphologic pattern of lung injury that results from multiple causes with varying pathogenetic mechanisms rather than a distinct disease entity (1). However, a few cases of LIP do present as idiopathic disease. LIP therefore is still included in recent classifications of idiopathic interstitial pneumonias (7). 

---